Cargando…
Effects of Persisting Emotional Impact from Child Abuse and Norepinephrine Transporter Genetic Variation on Antidepressant Efficacy in Major Depression: A Pilot Study
OBJECTIVE: Previous studies suggest child abuse and serotonergic polymorphism influence depression susceptibility and anti-depressant efficacy. Polymorphisms of the norepinephrine transporter (NET) may also be involved. Research in the area is possibly clouded by under reporting of abuse in research...
Autores principales: | Singh, Ajeet Bhagat, Bousman, Chad A., Ng, Chee Hong, Byron, Keith, Berk, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423165/ https://www.ncbi.nlm.nih.gov/pubmed/25912538 http://dx.doi.org/10.9758/cpn.2015.13.1.53 |
Ejemplares similares
-
Concordance between actual and pharmacogenetic predicted desvenlafaxine dose needed to achieve remission in major depressive disorder: a 10-week open-label study
por: Bousman, Chad A., et al.
Publicado: (2017) -
Subcellular localization of the antidepressant-sensitive norepinephrine transporter
por: Matthies, Heinrich JG, et al.
Publicado: (2009) -
Antidepressant prescribing in the precision medicine era: a prescriber’s primer on pharmacogenetic tools
por: Bousman, Chad A., et al.
Publicado: (2017) -
ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression
por: Singh, A B, et al.
Publicado: (2012) -
The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 Report
por: Harkness, Kate L., et al.
Publicado: (2023)